Comparison of Methods to Detect and Measure Glaucomatous Visual Field Progression

Abstract

Purpose: To compare methods to assess visual field (VF) progression in glaucoma. Methods: 4,950 VFs of 253 primary open angle-glaucoma patients were evaluated for progression with the following methods: clinical evaluation, guided progression analysis (GPA), mean deviation (MD), and visual field index (VFI) rates, Advanced Glaucoma Intervention Study (AGIS) and Collaborative Initial Glaucoma Treatment Study (CIGTS) scores, pointwise linear regression (PLR), permutation of PLR (PoPLR), and glaucoma rate index (GRI). A separate simulated series of longitudinal VFs was assessed with all methods except for GPA and clinical evaluation. Results: The average (6SD) age of the patients at baseline was 65.4 (611.5) years. The average (6SD) follow-up was 11.8 (64.6) years, and the mean (6SD) number of VFs was 16.8 (67.0). Proportion of series detected as progressing was 65% for PoPLR, 58% for GRI, 41% for GPA, 40% for PLR, 36% for CIGTS, 35% for clinicians, 31% for MD rate, 29% for AGIS, and 22% for VFI rate. Median times to detection of progression were 7.3 years for PoPLR, 7.5 years for GRI, 11 years for clinicians, 14 years for GPA, 16 years for PLR, 17 years for CIGTS, 19 years for AGIS, and more than 20 years for MD and VFI rates. In simulated VF series, GRI had the highest partial area under the receiver operator characteristic curve (0.040) to distinguish between glaucoma progression and aging/cataract decay, followed by VFI rate (0.028), MD rate (0.024), and PoPLR (0.006). Conclusions: GRI and PoPLR showed the highest proportion of series detected as progressing and shortest times to progression detection. GRI exhibited the best ability to detect progression in the simulated VF series. Translational Relevance: Knowledge of the properties of every method would allow tailoring application in both clinical and research settings.

Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice

“…This is an ongoing challenge even in current clinical practice and will further impact the generalizability of innovations derived through AI to individual clinical settings. 109 – 111 In addition, considerable ocular variability occurs within patient populations depending upon factors, such as age, gender, refractive error, medical comorbidities, and ethnicity. Before ML strategies can be translated to everyday clinical practice, further validation across diverse global patient populations is necessary.…”

Comparison of Rates of Progression of Macular OCT Measures in Glaucoma

“…A VF series was defined as progressing if there were more than or equal to three deteriorating test locations after accounting for improving locations. Because VF progression greatly depends on the method used to define progression, 20 , 21 we also repeated all the analyses using another pointwise PLR criterion (≥ 4 deteriorating test locations with a rate of change ≤ −1 dB/year at P < 0.05) as well as the regression of the global index MD against time (progression defined as negative rate of change at P < 0.05).…”

Longitudinal Macular Structure–Function Relationships in Glaucoma

“…To better control the specificity for detection of change with structural and functional measures, we applied permutation analyses and estimated rates of change at macular superpixels (GCC thickness) and VF test locations (TD values) 5000 times for followup periods from 2 to 5.5 years. 30 We defined the 95% confidence intervals for the individual estimated slopes and considered rates of change falling below the 2.5% cutoff point as representing "true" worsening.…”